Next Generation Sequencing (NGS) device with post-warranty service agreement options
Past Recompete Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Not on record
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Points of contact
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration's National Center for Toxicological Research is recompeting a Next Generation Sequencing device procurement to support its Microbiology Surveillance Program, with an estimated award date of August 1, 2026. The NGS device will identify and quantify potential pathogens in lab animals, biological samples, feeds, waters, environment, and bedding.
The estimated award value ranges from $25,000 to $250,000. Nick Sartain, Contracting Officer at the Food and Drug Administration, is the point of contact (nick.sartain@fda.hhs.gov, +1-301-796-1988).
Forecast text
National Center for Toxicological Research (NCTR), has a requirement for a next Generation Sequencing (NGS) device for the Microbiology Surveillance Program. The NGS device will be used to identify and quantify the potential pathogens in lab animals, biological samples, feeds, waters, environment, bedding, and feeds.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast